Our Core Research Team
We are twelve independent laboratories working together to find new ways to prevent cancers, better treat cancers and understand how they arise.
DNA Damage Repair Biology
Dr. Aaron Goodarzi
Understanding oxidative DNA damage after radiation exposure
Dr. David Schriemer
Integrative structural biology and proteomics
Dr. Ebba Kurz
Pharmacologic studies of genome instability & topoisomerase function.
Dr. Gareth Williams
The Structural Basis of DNA Repair
Dr. Jennifer Cobb
Genome instability as a consequence of replication of fragile DNA sites.
Dr. Susan Lees-Miller
DNA double strand break repair via non-homologous end-joining.
Cellular Aging Biology
Dr. Jennifer Cobb
Genome instability as a consequence of replication of fragile DNA sites.
Dr. Karl Riabowol
Roles of the ING-family tumor suppressors in cancer and normal aging.
Dr. Tara Beattie
Canonical and non-canonical roles for telomerase in human disease.
Anti-Cancer Clinical Trials
Dr. Corinne Doll
Functional indicators of cervical and anal cancer response to radiation and chemoradiation therapy
Dr. Gwyn Bebb
Genome instability markers in human lung cancer and lymphoma.
Dr. Nizar Bahlis
Synergistic PARP & proteasome inhibition as multiple myeloma therapy.
Cancer Exposome Science
Dr. Aaron Goodarzi
Understanding oxidative DNA damage after radiation exposure
Dr. Darren Brenner
Molecular biomarkers for cancer risk prediction
Dr. David Schriemer
Integrative structural biology and proteomics
Dr. Jennifer Cobb
Genome instability as a consequence of replication of fragile DNA sites.